Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
J Autoimmun 40(7):532539 Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, Zisopoulos D, Skopouli FN, Iliopoulos A, Bertsias GK (2014) Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: low rates of remission and 5-year drug survival
G., Nesvizhskii, A
doi: 10.1016/0891-5849(92)90147-9
A1AT appears to inhibit viral infection by targeting two crucial proteases involved in the pathophysiology of the virus: the transmembrane serine protease 2 (TMPRSS2) and the ADAM17 (123, 124)
US$ 26.41
US$ 20.35
US$ 26.84
US$ 26.10
